Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2003
10/22/2003EP1056701B1 E-2- 4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol and pharmaceutical compositions thereof
10/22/2003EP1047665B1 Matrix metalloprotease inhibitors
10/22/2003EP0815221B1 A novel growth factor and a genetic sequence encoding same
10/22/2003EP0699069B9 Endothelin receptor antagonists
10/22/2003EP0658209B1 Endothelial lineage specific transcriptional regulatory element from tek
10/22/2003EP0651654B1 Use of lysozyme dimer for the manufacture of a medicament for modulating natural defensive mechanisms
10/22/2003CN1451010A Benzosulfones with calcium antagonist activity
10/22/2003CN1451004A 7-oxo pyridopyrimidines
10/22/2003CN1450999A Novel piperazine derivatives
10/22/2003CN1450998A Inhibitors of copper-containing amine oxidases
10/22/2003CN1450997A Inhibitors of copper-containing amine oxidases
10/22/2003CN1450996A 2-guanidino-4-aryl-quinazoline
10/22/2003CN1450905A Method for improving the cell protection
10/22/2003CN1450894A Phenylethylamines and condensed rings variants as prodrugs of catecholamines and their use
10/22/2003CN1450891A Formulation based on heparin, glycosaminogl ycan or heparinoid, use of the formulation and the formulation base
10/22/2003CN1450085A Human red blood cell source depressor factor and use thereof
10/22/2003CN1450066A Porphyrin derivate with macrosubstituent, preparation process thereof and use as small molecule antioxidant
10/22/2003CN1449817A Traditional Chinese medicine capable of anti-SARS and treating cardio-cerebral vascular embolism
10/22/2003CN1449807A Yinxingle capsule and XinnaoXuekang capsule
10/22/2003CN1449796A Capsule containing ginkgo leaf extract
10/22/2003CN1449779A Pure Chinese medicine preparation for treating angiitis and preparation process thereof
10/22/2003CN1449765A Puerarin soft capsule pharmaceutics and preparation process thereof
10/22/2003CN1449763A Soy daidzin composition and preparation process and use thereof
10/22/2003CN1449759A Prostaglandin E1 liposome frozen dry powder injection and production technology thereof
10/22/2003CN1449756A Difenidol Hydrochloride oral disintegrating tablet and preparation process thereof
10/22/2003CN1125082C Human chemokine beta-8 chemokine beta-1 and macrophage inflammatory protein-4
10/22/2003CN1125054C Novel imidazolidine derivatives, their preparation their use and pharmaceutical preparations comprising them
10/22/2003CN1125052C Substituted isoquinoline derivatives and their use as anticonvulsants
10/22/2003CN1125049C New crystal modification N of torasemide
10/22/2003CN1125047C Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy) ethylamino]-2-propanole process for its preparation and pharmaceutical use
10/22/2003CN1124857C Chinese medicine prepn for treating cerebral thrombus hypertension and cerebral arteriosclerosis and its production process
10/22/2003CN1124856C Pill for treating hemiplegia
10/21/2003US6635786 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
10/21/2003US6635776 Lipoxin compounds and their use in treating cell proliferative disorders
10/21/2003US6635765 Processes for preparing torsemide intermediate
10/21/2003US6635680 Controlled release pellet formulation
10/21/2003US6635671 Compounds which affect mRNA stability and uses therefor
10/21/2003US6635669 Kinase inhibitor; benign prostatic hyperplasia
10/21/2003US6635657 Pyridine derivatives; anticoagulants
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/21/2003US6635651 Inhibitors of thrombin induced platelet aggregation
10/21/2003US6635650 Such as N-(2-(7-(2-((8-(2-(acetyl-amino)ethyl)-2-naphthyl) oxy)ethoxy)-1-napthyl)ethyl)acetamide for treating or preventing melatoninergic disorders
10/21/2003US6635648 Combination therapy using sympathetic nervous system antagonists and endothelin antagonists
10/21/2003US6635645 2,5,-diazabicyclo[2.2.1]heptane derivatives, their preparation and therapeutic uses
10/21/2003US6635644 Pyrimido(1,6-b)pyridazine derivatives used as p38 inhibitors a mammalian protein kinase is involved in cell proliferation, cell death and response to extracellular stimuli
10/21/2003US6635642 Poly(ADP-ribose) polymerase inhibitors; tissue damage treatment
10/21/2003US6635640 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
10/21/2003US6635638 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/21/2003US6635637 Cyclic oxyguanidine protease inhibitors
10/21/2003US6635629 For therapy and prophylaxis of inflammation, asthma, an allergic disease, chronic obstructive pulmonary disease, atopic dermatitis, solid tumors, AIDS, ischemia, and cardiac arrhythmias
10/21/2003US6635621 Alpha amino acid amide derivatives; reducing cathepsins B, L, S and/or K activity
10/21/2003US6635619 Amino acid sequence 88, 96, 97, 98, 99 or 100; increasing serum and tissue levels of active component
10/21/2003US6635473 Isolated nucleic acid encoding a fibrinogen-binding protein; useful in prevention, diagnosis and treatment of infections; can be administered to wounds or for coating prosthetics to inhibit binding of the bacteria
10/21/2003US6635451 Conversion of dihomo-gamma linolenic acid (DGLA) to arachidonic acid and in the conversion of 20:4n-3 to eicosapentaenoic acid (EPA); Delta 6 desaturase and Delta 5 desaturase
10/21/2003US6635431 Recombinant lipolysis stimulated (LSR) comprising polypeptide of given sequence; use for selecting a compound for enhancing lipoprotein uptake in cells expressing the polypeptide
10/21/2003US6635273 Methods of treating vascular diseases characterized by nitric oxide insufficiency
10/21/2003US6635270 NMDA receptor agonist pharmaceutical compositions
10/21/2003US6635252 Antibodies to superoxide dismutase-4
10/21/2003US6635249 Methods for treating congestive heart failure
10/21/2003US6635045 Silver/silver chloride; reservoir comprising aqueous sodium chloride dispersed therein; corrosion resistance; transdermal
10/21/2003CA2237401C Novel intermediates and their use to prepare n,n'-bridged bisindolylmaleimides
10/21/2003CA2156825C Inhibition of intimal hyperplasia using antibodies to pdgf receptors
10/21/2003CA2141964C Pharmaceutical agents containing diphosphonic acids and salts thereof
10/21/2003CA2081344C Use of 5-ht4 receptor antagonists in the treatment of arrythmias and stroke
10/21/2003CA2060326C Antiarrhythmic tertiary amine-alkenyl-phenyl-alkanesulfonamides
10/16/2003WO2003085377A2 Novel pancortin-pablo protein interactions and methods of use thereof
10/16/2003WO2003085119A1 METHOD OF ENHANCING ACTIVITY OF ANTIBODY COMPOSITION OF BINDING TO FcϜ RECEPTOR IIIa
10/16/2003WO2003085118A1 Process for producing antibody composition
10/16/2003WO2003085107A1 Cells with modified genome
10/16/2003WO2003085102A1 Cell with depression or deletion of the activity of protein participating in gdp-fucose transport
10/16/2003WO2003084975A1 New analogs of nitrobenzylthioinosine
10/16/2003WO2003084961A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/16/2003WO2003084956A1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
10/16/2003WO2003084955A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity
10/16/2003WO2003084954A1 Tropane derivatives as ccr5 modulators
10/16/2003WO2003084952A1 Benzoxazinone-derived compounds, their preparation und use as medicaments
10/16/2003WO2003084951A1 (3z) -3-(3-hydro-isobenzofuran-1-ylidene)-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
10/16/2003WO2003084948A1 Nitrogenous heterocyclic compound and medicine thereof
10/16/2003WO2003084943A2 Terphenyl derivatives, preparation thereof, compositions containing same
10/16/2003WO2003084941A2 Hydroxamic acid derivatives
10/16/2003WO2003084940A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003WO2003084939A1 Benzoxazinone derivatives, the preparation and use thereof as medicaments
10/16/2003WO2003084938A2 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
10/16/2003WO2003084937A2 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases
10/16/2003WO2003084936A2 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
10/16/2003WO2003084935A2 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases
10/16/2003WO2003084926A2 Polymeric acyl derivatives of indoles
10/16/2003WO2003084916A2 Compounds that modulate ppar activity and methods for their preparation
10/16/2003WO2003084915A1 Novel thyroid receptor ligands
10/16/2003WO2003084582A1 Embolization
10/16/2003WO2003084572A1 Medicinal composition comprising acat inhibitor and insuline resistance improving agent
10/16/2003WO2003084570A1 DRUG CONTAINING ANTIBODY COMPOSITION APPROPRIATE FOR PATIENT SUFFERING FROM FcϜRIIIa POLYMORPHISM
10/16/2003WO2003084569A1 Drug containing antibody composition
10/16/2003WO2003084567A1 Use of botulinum toxin for treating cardiovasular diseases
10/16/2003WO2003084566A2 Proteins involved in the regulation of energy homeostasis
10/16/2003WO2003084565A2 Ve-ptp as regulator of ve-cadherin mediated processes or disorders
10/16/2003WO2003084563A1 Glp-1 agonist and cardiovascular complications
10/16/2003WO2003084560A2 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
10/16/2003WO2003084549A1 Hormone replacement therapy
10/16/2003WO2003084544A2 Compounds dor increasing abca-1 expression useful for treating coronary artery disease and atherosclerosis
1 ... 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 ... 1595